Takeda Pharmaceutical Company Limited Postemployment Benefit Expense Defined Contribution Plans
Takeda Pharmaceutical Company Limited (TAK) reported Postemployment Benefit Expense Defined Contribution Plans of JPY 52.69 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans · last filed 2025-06-25
| Period end | Postemployment Benefit Expense Defined Contribution Plans 12 month |
|---|---|
| 2025-03-31 | 52.69B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 60.52B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 46.45B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 37.34B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 34.05B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | 25.14B JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | 21.07B JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | 19.52B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | 20.90B JPY 20-F · filed 2019-06-27 |